Active Lung and Upper Aerodigestive Cancer Grants

PI Name Organization - Companysort descending Title Major Program / Research Group FOA
You, Ming Methodist Hospital Research Institute Inhibition of Oral Tumorigenesis by Antitumor B PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Khan, Seema Ahsan Northwestern University At Chicago Northwestern Cancer Prevention Consortium Cancer Prevention Clinical Trials Network RFA-CA-18-029: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites
Mallery, Susan R Ohio State University Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Mallery, Susan R Ohio State University Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Yendamuri, Saikrishna Roswell Park Cancer Institute Corp Metformin for chemoprevention of lung cancer in obese subjects at high risk PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Krasnow, Mark A Stanford University Molecular mechanisms of SCLC initiation and detection in mice and humans Small Cell Lung Cancer Consortium PAR-16-051: Small-Cell Lung Cancer (SCLC) Consortium: Innovative Approaches to the Prevention and Early Detection of Small Cell Lung Cancer
Chow, H-H. Sherry University Of Arizona University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) Cancer Prevention Clinical Trials Network RFA-CA-18-029: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites
Tennis, Meredith A University Of Colorado Denver Frizzled 9 loss and regulation in preventing the progression of pre-malignant lung lesions PA-16-160: NIH Research Project Grant
Ghosh, Moumita University Of Colorado Denver (PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Brenner, Dean E. University Of Michigan At Ann Arbor Early Phase Clinical Cancer Prevention Consortium Cancer Prevention Clinical Trials Network RFA-CA-19-031: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites
Ondrey, Frank G. University Of Minnesota Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Brown, Powel H University Of Tx Md Anderson Can Ctr iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium Cancer Prevention Clinical Trials Network RFA-CA-18-029: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites
Park, Kwon-Sik University Of Virginia Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC Small Cell Lung Cancer Consortium PAR-16-051: Small-Cell Lung Cancer (SCLC) Consortium: Innovative Approaches to the Prevention and Early Detection of Small Cell Lung Cancer
Kim, Kyungmann University Of Wisconsin-Madison CP-CTNet Coordinating Center Cancer Prevention Clinical Trials Network RFA-CA-18-030: Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC)
Bailey, Howard H. University Of Wisconsin-Madison The MW Cancer Prevention Clinical Trials Network Cancer Prevention Clinical Trials Network RFA-CA-19-031: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites

Pages